Modular Medical, Inc. (MODD)
USD 0.97
(-6.43%)
USD 0.97
(-6.43%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 17.52 Million USD | 26.3% |
| 2023 | 13.87 Million USD | -7.02% |
| 2022 | 14.92 Million USD | 103.45% |
| 2021 | 7.33 Million USD | 37.19% |
| 2020 | 5.34 Million USD | 107.5% |
| 2019 | 2.57 Million USD | 286.89% |
| 2018 | 666.16 Thousand USD | 631.64% |
| 2017 | 91.05 Thousand USD | 591.72% |
| 2016 | 13.16 Thousand USD | -18.32% |
| 2015 | 16.11 Thousand USD | 49.6% |
| 2014 | 10.77 Thousand USD | -1.36% |
| 2013 | 10.92 Thousand USD | 14.79% |
| 2012 | 9513.00 USD | 3.7% |
| 2011 | 9174.00 USD | 19.64% |
| 2010 | 7668.00 USD | -18.43% |
| 2009 | 9400.00 USD | 39.96% |
| 2008 | 6716.00 USD | 3.61% |
| 2007 | 6482.00 USD | -27.22% |
| 2006 | 8906.00 USD | -37.67% |
| 2005 | 14.28 Thousand USD | 130.21% |
| 2004 | 6207.00 USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 3.75 Million USD | 5.0% |
| 2024 FY | 16.76 Million USD | 20.77% |
| 2024 Q4 | 4.08 Million USD | -20.43% |
| 2024 Q2 | 4.19 Million USD | 11.7% |
| 2024 Q3 | 5.13 Million USD | 22.65% |
| 2023 FY | 13.87 Million USD | -7.02% |
| 2023 Q1 | 3.49 Million USD | -13.12% |
| 2023 Q4 | 3.57 Million USD | 6.38% |
| 2023 Q3 | 3.35 Million USD | -2.64% |
| 2023 Q2 | 3.44 Million USD | -1.43% |
| 2022 FY | 14.92 Million USD | 103.45% |
| 2022 Q1 | 3.37 Million USD | 94.69% |
| 2022 Q2 | 3.69 Million USD | 9.51% |
| 2022 Q3 | 3.83 Million USD | 3.7% |
| 2022 Q4 | 4.02 Million USD | 5.12% |
| 2021 Q2 | 1.85 Million USD | -0.8% |
| 2021 Q4 | 1.73 Million USD | -7.37% |
| 2021 Q1 | 1.87 Million USD | -2.21% |
| 2021 Q3 | 1.87 Million USD | 0.61% |
| 2021 FY | 7.33 Million USD | 37.19% |
| 2020 FY | 5.34 Million USD | 107.5% |
| 2020 Q1 | 1.13 Million USD | 11.31% |
| 2020 Q2 | 1.15 Million USD | 1.68% |
| 2020 Q3 | 1.13 Million USD | -1.86% |
| 2020 Q4 | 1.91 Million USD | 68.74% |
| 2019 FY | 2.57 Million USD | 286.89% |
| 2019 Q1 | 255.19 Thousand USD | 37.8% |
| 2019 Q2 | 548.99 Thousand USD | 115.13% |
| 2019 Q3 | 750.56 Thousand USD | 36.71% |
| 2019 Q4 | 1.02 Million USD | 36.24% |
| 2018 FY | 666.16 Thousand USD | 631.64% |
| 2018 Q3 | 260.86 Thousand USD | 47.96% |
| 2018 Q2 | 176.3 Thousand USD | 120.0% |
| 2018 Q1 | 80.13 Thousand USD | 3555.98% |
| 2018 Q4 | 185.19 Thousand USD | -29.01% |
| 2017 Q1 | 1753.00 USD | -18.16% |
| 2017 FY | 91.05 Thousand USD | 591.72% |
| 2017 Q4 | 2192.00 USD | -12.04% |
| 2017 Q3 | 2492.00 USD | -59.99% |
| 2017 Q2 | 6228.00 USD | 255.28% |
| 2016 Q4 | 2142.00 USD | -11.38% |
| 2016 Q2 | 6851.00 USD | 89.41% |
| 2016 Q1 | 3617.00 USD | -12.14% |
| 2016 Q3 | 2417.00 USD | -64.72% |
| 2016 FY | 13.16 Thousand USD | -18.32% |
| 2015 Q1 | 1742.00 USD | -18.98% |
| 2015 FY | 16.11 Thousand USD | 49.6% |
| 2015 Q2 | 4524.00 USD | 159.7% |
| 2015 Q4 | 4117.00 USD | 6.74% |
| 2015 Q3 | 3857.00 USD | -14.74% |
| 2014 Q3 | 2475.00 USD | -43.81% |
| 2014 Q1 | 2050.00 USD | 0.0% |
| 2014 Q2 | 4405.00 USD | 114.88% |
| 2014 Q4 | 2150.00 USD | -13.13% |
| 2014 FY | 10.77 Thousand USD | -1.36% |
| 2013 Q2 | 4705.00 USD | 248.52% |
| 2013 FY | 10.92 Thousand USD | 14.79% |
| 2013 Q1 | 1350.00 USD | -32.09% |
| 2013 Q4 | 2050.00 USD | -3.07% |
| 2013 Q3 | 2115.00 USD | -55.05% |
| 2012 Q1 | 2047.00 USD | 20.41% |
| 2012 FY | 9513.00 USD | 3.7% |
| 2012 Q4 | 1988.00 USD | 5.8% |
| 2012 Q3 | 1879.00 USD | -56.26% |
| 2012 Q2 | 4296.00 USD | 109.87% |
| 2011 Q2 | 3917.00 USD | 360.82% |
| 2011 Q1 | 850.00 USD | -50.29% |
| 2011 FY | 9174.00 USD | 19.64% |
| 2011 Q4 | 1700.00 USD | 12.58% |
| 2011 Q3 | 1510.00 USD | -61.45% |
| 2010 Q1 | 575.00 USD | -52.08% |
| 2010 FY | 7668.00 USD | -18.43% |
| 2010 Q4 | 1710.00 USD | 76.11% |
| 2010 Q3 | 971.00 USD | -76.53% |
| 2010 Q2 | 4137.00 USD | 619.48% |
| 2009 Q2 | 6355.00 USD | 531.08% |
| 2009 Q3 | 1270.00 USD | -80.02% |
| 2009 Q4 | 1200.00 USD | -5.51% |
| 2009 FY | 9400.00 USD | 39.96% |
| 2009 Q1 | 1007.00 USD | 17.37% |
| 2008 Q3 | 940.00 USD | -75.97% |
| 2008 FY | 6716.00 USD | 3.61% |
| 2008 Q4 | 858.00 USD | -8.72% |
| 2008 Q2 | 3911.00 USD | 6961.4% |
| 2008 Q1 | -57.00 USD | -104.83% |
| 2007 FY | 6482.00 USD | -27.22% |
| 2007 Q2 | 3567.00 USD | 285.62% |
| 2007 Q3 | 1792.00 USD | -49.76% |
| 2007 Q4 | 1180.00 USD | -34.15% |
| 2007 Q1 | 925.00 USD | -41.05% |
| 2006 Q4 | 1569.00 USD | 10.81% |
| 2006 Q2 | 4996.00 USD | 36.84% |
| 2006 FY | 8906.00 USD | -37.67% |
| 2006 Q1 | 3651.00 USD | 105.57% |
| 2006 Q3 | 1416.00 USD | -71.66% |
| 2005 FY | 14.28 Thousand USD | 130.21% |
| 2005 Q3 | 4544.00 USD | 5.23% |
| 2005 Q2 | 4318.00 USD | 0.0% |
| 2005 Q4 | 1776.00 USD | -60.92% |
| 2004 FY | 6207.00 USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -56.174% |
| Cerus Corporation | 143.15 Million USD | 87.755% |
| OrthoPediatrics Corp. | 137.01 Million USD | 87.207% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -54.293% |
| Talis Biomedical Corporation | 67.18 Million USD | 73.91% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 29.732% |
| Inogen, Inc. | 236.08 Million USD | 92.575% |
| Spectral AI, Inc. | 20.86 Million USD | 15.984% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 68.697% |
| CVRx, Inc. | 76.14 Million USD | 76.979% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -396.854% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -40.356% |
| Orthofix Medical Inc. | 667.42 Million USD | 97.374% |
| Venus Concept Inc. | 80.47 Million USD | 78.218% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 69.018% |
| Bioventus Inc. | 409.91 Million USD | 95.724% |
| BrainsWay Ltd. | 28.01 Million USD | 37.437% |
| Envoy Medical, Inc. | 17.89 Million USD | 2.062% |
| electroCore, Inc. | 32.03 Million USD | 45.275% |
| IceCure Medical Ltd | 16.87 Million USD | -3.869% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 58.689% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 0.59% |
| MaxCyte, Inc. | 84.84 Million USD | 79.34% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -41.229% |
| Nexalin Technology, Inc. | 5.78 Million USD | -203.199% |
| PAVmed Inc | 64.82 Million USD | 72.96% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 65.682% |
| RxSight, Inc. | 103.85 Million USD | 83.121% |
| Sight Sciences, Inc. | 126.44 Million USD | 86.137% |
| SI-BONE, Inc. | 156.35 Million USD | 88.789% |
| TELA Bio, Inc. | 84.18 Million USD | 79.178% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 74.979% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 91.381% |
| LivaNova PLC | 843.54 Million USD | 97.922% |
| 908 Devices Inc. | 68.08 Million USD | 74.252% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 96.375% |
| Nemaura Medical Inc. | 7.13 Million USD | -145.545% |
| NeuroPace, Inc. | 75.29 Million USD | 76.72% |
| LENSAR, Inc. | 33.33 Million USD | 47.417% |
| Apyx Medical Corporation | 51.01 Million USD | 65.642% |
| Cutera, Inc. | 197.72 Million USD | 91.135% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 29.264% |
| BioSig Technologies, Inc. | 28.53 Million USD | 38.559% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 90.845% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 51.389% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 97.904% |
| Axonics, Inc. | 270.2 Million USD | 93.513% |
| Outset Medical, Inc. | 198.77 Million USD | 91.181% |
| IRIDEX Corporation | 31.81 Million USD | 44.902% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 90.274% |
| IRadimed Corporation | 30.12 Million USD | 41.808% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -105.45% |
| INVO Bioscience, Inc. | 7.85 Million USD | -123.206% |
| Telesis Bio, Inc. | 63.48 Million USD | 72.39% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 82.196% |
| Varex Imaging Corporation | 224.8 Million USD | 92.202% |
| Quipt Home Medical Corp. | 148.66 Million USD | 88.209% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -49.527% |
| Pulmonx Corporation | 112.68 Million USD | 84.445% |
| Dynatronics Corporation | 9.9 Million USD | -76.917% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 13.167% |
| Semler Scientific, Inc. | 38.94 Million USD | 54.989% |
| InMode Ltd. | 215.68 Million USD | 91.873% |
| Bruker Corporation | 1.07 Billion USD | 98.372% |
| Cytosorbents Corporation | 48.33 Million USD | 63.736% |
| DexCom, Inc. | 1.69 Billion USD | 98.964% |
| Align Technology, Inc. | 2.07 Billion USD | 99.156% |
| Viveve Medical, Inc. | 22.17 Million USD | 20.944% |
| ZimVie Inc. | 275.12 Million USD | 93.629% |
| Movano Inc. | 29.69 Million USD | 40.96% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 87.23% |
| Nexalin Technology, Inc. | 5.78 Million USD | -203.199% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -396.854% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 97.083% |
| Profound Medical Corp. | 33.6 Million USD | 47.835% |
| Insulet Corporation | 939.9 Million USD | 98.135% |
| enVVeno Medical Corporation | 25.23 Million USD | 30.545% |
| Surmodics, Inc. | 98.69 Million USD | 82.24% |
| iCAD, Inc. | 22.22 Million USD | 21.129% |
| Nuwellis, Inc. | 22.61 Million USD | 22.483% |
| Biotricity, Inc. | 17.18 Million USD | -2.004% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 96.069% |
| Aethlon Medical, Inc. | 12.27 Million USD | -42.773% |
| InspireMD, Inc. | 22.95 Million USD | 23.621% |
| PAVmed Inc. | 64.82 Million USD | 72.96% |
| BIOLASE, Inc. | 34.66 Million USD | 49.427% |
| Beyond Air, Inc. | 61.7 Million USD | 71.59% |
| FONAR Corporation | 28.6 Million USD | 38.72% |
| AxoGen, Inc. | 149.33 Million USD | 88.262% |
| Vivani Medical, Inc. | 26.96 Million USD | 34.994% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 90.102% |
| Inari Medical, Inc. | 448.59 Million USD | 96.092% |
| UFP Technologies, Inc. | 58.08 Million USD | 69.824% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -255.731% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -177.433% |
| Tenon Medical, Inc. | 16.96 Million USD | -3.306% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -137.103% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 60.254% |
| AdaptHealth Corp. | 1.07 Billion USD | 98.374% |
| Sintx Technologies, Inc. | 15.2 Million USD | -15.315% |
| NanoVibronix, Inc. | 4.97 Million USD | -252.483% |
| Quanterix Corporation | 118.1 Million USD | 85.157% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -49.527% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -21.375% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 95.536% |
| TransMedics Group, Inc. | 182.82 Million USD | 90.412% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 37.541% |
| NeuroMetrix, Inc. | 11.09 Million USD | -57.934% |
| Hyperfine, Inc. | 52.87 Million USD | 66.846% |
| Establishment Labs Holdings Inc. | 172 Million USD | 89.809% |
| Biomerica, Inc. | 6.97 Million USD | -151.204% |
| Bone Biologics Corporation | 9.42 Million USD | -85.919% |
| AVITA Medical, Inc. | 80.77 Million USD | 78.3% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -69.999% |
| Silk Road Medical, Inc | 186.35 Million USD | 90.594% |